- Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted?New precision medicines effectively target KRAS mutations in lung, colon, and other cancers.
- Ask the Experts About Circulating Tumor DNA in the Management of CancerAsk the Experts About Circulating Tumor DNA (ctDNA) in the Management of Cancer
- FDA Grants Fast Track Designation to STRO-002 for Advanced Ovarian CancerLearn about the STRO-002 Antibody-drug conjugate in Ovarian Cancer
- Dacogen Effective in Advanced Myeloproliferative NeoplasmsDacogen Effective in Advanced Phases of MPN
- Jakafi Does'nt Increase Risk of New CancersStudy suggests Jakafi not associated with increase in significant secondary malignancies.
- TILs + Opdivo Produce Remissions in Advanced Lung CancerCould TILs represent the next advance in the treatment of lung cancer?
- Driving advances in breast cancer surgeryThe latest advances in novel surgical techniques which are improving outcomes for breast cancer patients.
- 5 Ways to Support Your Mental Wellness During Radiation TherapyActivity, Nutrition and Mental Health-Essential for Cancer Treatment Success
- Does Preoperative Immunotherapy Improve Treatment of Locally Advanced Rectal Cancer?Immunotherapy May Improve Treatment of Rectal Cancer
- Ipatasertib Precision Cancer Medicine for Prostate CancerAccording to the results of a recent clinical study aggressive prostate cancers may be treated more effectively by combining an existing targeted medicine, Zytiga (abiraterone) with a new experimental drug to block two of cancer’s growth signals at once. The combination delayed prostate cancers ...
